BiotechTube
Home/Liquidia Corporation/Paul B. Manning
PB

Paul B. Manning

Director

Liquidia Corporation

Roles

DirectoratLiquidia Corporation
Chairman of the BoardatVerrica Pharmaceuticals

Therapeutic Areas

Pulmonary HypertensionRare DiseasesCardiopulmonary

Liquidia Corporation Pipeline

DrugIndicationPhase
YUTREPIA™ (treprostinil) inhalation powderPulmonary Arterial Hypertension (PAH)Approved (Tentative)
LIQ861 (treprostinil) inhalation powderPulmonary Arterial Hypertension (PAH)Phase 3
L606 (liposomal treprostinil) injectionPulmonary Arterial Hypertension (PAH) and other rare pulmonary diseasesPre-clinical

Leadership Team at Liquidia Corporation

RA
Roger A. Jeffs, Ph.D.
Chief Executive Officer & Director
MK
Michael Kaseta
Chief Financial Officer & Treasurer
TS
Tushar Shah, M.D.
Chief Medical Officer
RJ
Robin J. Steele
Chief Commercial Officer
JA
Jason Adair
Chief Operating Officer
DL
David L. Tome
General Counsel & Corporate Secretary
RS
Rajiv Shukla
Chairman of the Board
JP
John P. Hamill
Director
AM
Anne M. Phillips, M.D.
Director
KG
Kelley G. Downing
Director
View full Liquidia Corporation profile